Vimarsana
Biggest News Aggregation in the World

View Publication News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from View Publication. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In View Publication Today - Breaking & Trending Today

Alpine Immune Sciences Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results - Vimarsana News

Alpine Immune Sciences Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results

Published: March 24, 2023

23.03.2023 - Alpine Immune Sciences, Inc. (NASDAQ: ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for autoimmune and inflammatory diseases, today provided a corporate update and reported financial results for ...

Source: wallstreet-online.de
Related Topics:
United StatesJames TumlinAlpine Immune SciencesExchange CommissionList Of Company PublicationsAmerican Academy Of Dermatology Annual Meeting OnAlpine Immune Sciences IncAlpine Immune Sciences StockSecurities ExchangeNephronet Clinical Trials ConsortiumMedical DirectorEmory University SchoolRecent PipelineView PublicationAmerican AcademyAnnual MeetingFull ListCompany PublicationsTruveta StudioFull YearImmune SciencesSecurities ActSecurities Exchange ActPrivate SecuritiesLitigation Reform Act
Alpine Immune Sciences Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results - Vimarsana News

Alpine Immune Sciences Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results

Published: March 23, 2023

RUBY-3, a basket study of povetacicept in autoimmune glomerulonephritis, has initiated patient enrollment; RUBY-4, a basket study of povetacicept in autoimmune cytopenias, targets initiation in Q2... | March 23, 2023

Source: marketscreener.com
Related Topics:
United StatesJames TumlinExchange CommissionList Of Company PublicationsAlpine Immune Sciences IncAmerican Academy Of Dermatology Annual Meeting OnSecurities ExchangeAlpine Immune SciencesNephronet Clinical Trials ConsortiumExecutive ChairmanChief Executive OfficerMedical DirectorEmory University SchoolRecent PipelineView PublicationAmerican AcademyDermatology Annual MeetingFull ListCompany PublicationsTruveta StudioFull YearImmune SciencesSecurities ActSecurities Exchange ActPrivate Securities Litigation Reform Act